Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This trial is being conducted to assess the effects of Rotigotine over Placebo on improvement of Apathy and motor symptoms in subjects with early-stage and advanced stage idiopathic Parkinson´s Disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Therapy with a Dopamine agonist
Discontinuation from pervious therapy with a dopamine agonist after an adequate length of treatment, at adequate dose, due to lack of efficacy
Any medical or psychiatric condition that jeopardizes / compromises patient's ability for participation
Patient has received Neuroleptics, Dopamine releasing substances, Dopamine modulating substances, Alpha-Methyldopa, Metoclopramide, MAO-A inhibitors, Budipine, or Tolcapone
Electroconvulsive therapy
Patient has a
Primary purpose
Allocation
Interventional model
Masking
122 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal